Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Euglycaemic diabetic ketoacidosis.

J F Munro, I W Campbell, A C McCuish

    British Medical Journal
    |June 9, 1973
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patients as teachers: Evaluating the experiences of volunteer inpatients during medical student clinical skills training.

    Canadian medical education journal·2020
    Same author

    Which is the eligible patient to be treated with pioglitazone? The expert view.

    Journal of endocrinological investigation·2012
    Same author

    Treatment of "Refractory Obesity" with a diet of five meals a day.

    British medical journal·2010
    Same author

    Comparing the actions of older and newer therapies on body weight: to what extent should these effects guide the selection of antidiabetic therapy?

    International journal of clinical practice·2010
    Same author

    Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes.

    Current medical research and opinion·2007
    Same author

    Epidemiology and clinical presentation of type 2 diabetes.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006

    Severe euglycaemic ketoacidosis in young insulin-dependent diabetics is treatable. This study found that fluid and electrolyte replacement with insulin and carbohydrates, alongside careful bicarbonate monitoring, led to survival in all patients.

    Area of Science:

    • Endocrinology
    • Metabolic Disorders
    • Diabetic Ketoacidosis Management

    Background:

    • Diabetic metabolic decompensation can lead to severe euglycaemic ketoacidosis.
    • This condition primarily affects young, insulin-dependent diabetic patients.

    Purpose of the Study:

    • To analyze the characteristics and treatment outcomes of severe euglycaemic ketoacidosis in young insulin-dependent diabetics.
    • To evaluate the effectiveness of a specific treatment protocol for this condition.

    Main Methods:

    • Retrospective analysis of 211 episodes of diabetic metabolic decompensation.
    • Identification of 37 cases with severe euglycaemic ketoacidosis (blood glucose < 300 mg/100 ml, plasma bicarbonate ≤ 10 mEq/L).
    • Review of patient demographics, precipitating factors (vomiting, carbohydrate reduction), insulin regimens, and treatment protocols.

    Related Experiment Videos

    Main Results:

    • All 37 patients with severe euglycaemic ketoacidosis survived.
    • Common factors included vomiting and carbohydrate reduction with continued/increased insulin.
    • Treatment involved fluid/electrolyte replacement, ample insulin with carbohydrates (often 10% dextrose), and judicious alkali use.
    • Therapy was guided by serial plasma bicarbonate measurements.

    Conclusions:

    • Severe euglycaemic ketoacidosis in young insulin-dependent diabetics is a serious but manageable condition.
    • The described treatment approach, emphasizing fluid, electrolytes, insulin, carbohydrates, and bicarbonate monitoring, is effective and leads to survival.
    • Careful management of insulin dosage and carbohydrate intake is crucial in preventing and treating this complication.